- Trials with a EudraCT protocol (788)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
788 result(s) found for: Skin Cell.
Displaying page 1 of 40.
EudraCT Number: 2017-003495-31 | Sponsor Protocol Number: CCLL442X2201 | Start Date*: 2017-12-14 | |||||||||||
Sponsor Name:Novartis Pharma AG | |||||||||||||
Full Title: A randomized, Investigator-and patient-blind, placebo-controlled, parallel group first in human and proof of concept study to evaluate the safety, tolerability, and efficacy of CLL442 in patients w... | |||||||||||||
Medical condition: Cutaneous Squamous Cell Carcinoma in situ (SCCis) | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-003765-10 | Sponsor Protocol Number: I-Tackle | Start Date*: 2018-07-10 | |||||||||||
Sponsor Name:FONDAZIONE IRCCS "ISTITUTO NAZIONALE DEI TUMORI" | |||||||||||||
Full Title: Immunotherapy Followed By EGFR Inhibitor In Locally Advanced Or Metastatic Squamous Cell Cancer Of The Skin: Tackling Primary And Secondary Resistance | |||||||||||||
Medical condition: Patient with Locally Advanced Or Metastatic Squamous Cell Cancer Of The Skin | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2014-002175-28 | Sponsor Protocol Number: DACOMINT14 | Start Date*: 2014-08-04 | |||||||||||
Sponsor Name:Fondazione IRCCS Istituto Nazionale dei Tumori | |||||||||||||
Full Title: Efficacy and safety of single agent pan-HER inhibitor Dacomitinib in the treatment of locally advanced unresectable or metastatic squamous cell cancer of the skin or with clinical contraindication... | |||||||||||||
Medical condition: locally advanced unresectable or metastatic squamous cell cancer of the skin or with clinical contraindication to surgery | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2010-019260-37 | Sponsor Protocol Number: CCRC_2010/001 | Start Date*: 2010-07-21 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sponsor Name:Cork Cancer Research Centre | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Full Title: Electrochemotherapy versus conventional surgery in treatment of basal cell carcinoma | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Medical condition: Basal cell carcinoma of the skin | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial protocol: IE (Completed) | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2018-000141-39 | Sponsor Protocol Number: 110118 | Start Date*: 2018-03-08 | |||||||||||
Sponsor Name:Merete Hædersdal | |||||||||||||
Full Title: Tolerabililty of laser-assisted cisplatin+5-fluorouracil― an exploratory proof of concept study of topical combination chemotherapy for basal cell carcinoma | |||||||||||||
Medical condition: Patients over 18 years of age with a previously untreated superficial or nodular basal cell carcinoma (BCC) on the scalp, face, extremities or trunk | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-002843-14 | Sponsor Protocol Number: 0407 | Start Date*: 2017-09-26 | |||||||||||
Sponsor Name:Bispebjerg Hospital | |||||||||||||
Full Title: Investigations of local skin reactions and safety after combined treatment of basal cell carcinoma using ablative fractional laser and ingenol mebutate - an exloratory, prospective, open-label phas... | |||||||||||||
Medical condition: Safety and local skin reactions in patients with basal cell carcinoma after combined treatment of blative fractional laser and ingenol mebutate. | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-001708-12 | Sponsor Protocol Number: 4518000 | Start Date*: 2018-12-19 | |||||||||||
Sponsor Name:Alcedis GmbH | |||||||||||||
Full Title: A single arm phase II, open-label, multicenter trial to investigate the clinical activity and safety of avelumab in combination with cetuximab in subjects with unresectable stage III or stage IV cu... | |||||||||||||
Medical condition: Unresectable stage III or stage IV cutaneous squamous cell carcinoma (cSCC) | |||||||||||||
|
|||||||||||||
Population Age: Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2013-000092-33 | Sponsor Protocol Number: PDTA02_24.05.2013 | Start Date*: 2013-10-23 | |||||||||||
Sponsor Name:Medizinische Universität Wien, Univ.Klinik.f.Dermatologie | |||||||||||||
Full Title: Enhanced efficacy of photodynamic therapy in combination with 5% imiquimod -a randomised, prospective, observer-blinded study in patients with non melanoma skin cancer | |||||||||||||
Medical condition: non melanoma skin cancer | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2021-006372-17 | Sponsor Protocol Number: Field-Cancerization | Start Date*: 2022-02-15 | |||||||||||
Sponsor Name:Muehlenkreiskliniken AoeR | |||||||||||||
Full Title: Evaluation of clinical and immunological effects of PD-1 inhibition on actinic keratoses in patients with advanced or metastatic cutaneous squamous cell carcinoma in combination with a pronounced f... | |||||||||||||
Medical condition: advanced or metastatic cutaneous squamous cell carcinoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2019-001469-34 | Sponsor Protocol Number: NEO-CESQ | Start Date*: 2020-10-20 | |||||||||||
Sponsor Name:FONDAZIONE MELANOMA ONLUS | |||||||||||||
Full Title: A phase II, single arm study investigating neoadjuvant plus adjuvant treatment with Cemiplimab in high risk, surgically resectable, stage III Cutaneaous Squamous Cell Carcinoma | |||||||||||||
Medical condition: high risk, surgically resectable, stage III Cutaneous Squamous Cell Carcinoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2011-004305-24 | Sponsor Protocol Number: BCCItraconazole | Start Date*: 2012-04-18 | ||||||||||||||||
Sponsor Name:Med Uni Graz, Univ. Klinik Dermatologie,Abteilung für Allgemeine Dermatologie | ||||||||||||||||||
Full Title: Inhibition of the Hedgehog Pathway in Basal Cell Carcinomas of Patients treated with Itraconazole for Onychomycosis | ||||||||||||||||||
Medical condition: Basal cell carcinoma | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: AT (Completed) | ||||||||||||||||||
Trial results: View results |
EudraCT Number: 2013-003336-72 | Sponsor Protocol Number: 81413F | Start Date*: 2013-10-30 | |||||||||||
Sponsor Name:ISTITUTO EUROPEO DI ONCOLGIA | |||||||||||||
Full Title: A Phase IIb study of topic DAC-0060, a synthetic histone deacetylase inhibitor, plus Tazarotene in patients with cutaneous basal cell carcinoma (BCC) | |||||||||||||
Medical condition: BASAL CELL CARCINOMA | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-002508-16 | Sponsor Protocol Number: 53897 | Start Date*: 2016-08-31 | |||||||||||
Sponsor Name:Department of Dermatology D92, Bispebjerg Hospital | |||||||||||||
Full Title: Optimized photodynamic therapy for basal cell carcinoma | |||||||||||||
Medical condition: Basal cell carcinoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Prematurely Ended) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-004085-41 | Sponsor Protocol Number: 2007-003-0401-OPH. | Start Date*: 2009-01-15 | ||||||||||||||||
Sponsor Name:The Royal Wolverhampton Hospitals NHS Trust | ||||||||||||||||||
Full Title: Photodynamic Therapy for Basal Cell Carcinoma of the Eyelid and Periocular Skin with methyl aminolevulinate | ||||||||||||||||||
Medical condition: Periocular basal cell carcinoma | ||||||||||||||||||
|
||||||||||||||||||
Population Age: | Gender: Male, Female | |||||||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2016-003122-16 | Sponsor Protocol Number: R2810-ONC-1620 | Start Date*: 2017-09-28 | |||||||||||
Sponsor Name:Regeneron Pharmaceuticals, Inc. | |||||||||||||
Full Title: A PHASE 2 STUDY OF REGN2810, A FULLY HUMAN MONOCLONAL ANTIBODY TO PROGRAMMED DEATH-1, IN PATIENTS WITH ADVANCED BASAL CELL CARCINOMA WHO EXPERIENCED PROGRESSION OF DISEASE ON HEDGEHOG PATHWAY INHIB... | |||||||||||||
Medical condition: Metastatic basal cell carcinoma or unresectable locally advanced basal cell carcinoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: BE (Completed) DE (Completed) AT (Prematurely Ended) GR (Prematurely Ended) ES (Prematurely Ended) FR (Prematurely Ended) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2018-002605-62 | Sponsor Protocol Number: BCC1801 | Start Date*: 2018-10-23 | |||||||||||
Sponsor Name:Herlev and Gentofte Hospital | |||||||||||||
Full Title: Phase IIa trial with PD-L1 IO103 vaccination with montanide in patients with basal cell carcinoma. | |||||||||||||
Medical condition: basal cell carcinoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-005332-30 | Sponsor Protocol Number: ACT16845 | Start Date*: 2021-09-27 | ||||||||||||||||
Sponsor Name:SANOFI-AVENTIS RECHERCHE E DEVELOPPEMENT | ||||||||||||||||||
Full Title: A Phase 1/2 non-randomized, open-label, multi-cohort, multi-center study assessing the clinical benefit of SAR444245 (THOR- 707) combined with cemiplimab for the treatment of participants with adva... | ||||||||||||||||||
Medical condition: Advanced unresectable or metastatic skin cancers | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Ongoing) | ||||||||||||||||||
Trial results: (No results available) |
EudraCT Number: 2007-001961-14 | Sponsor Protocol Number: WN07DE002 | Start Date*: 2007-06-28 | |||||||||||
Sponsor Name:Greater Glasgow and Clyde [...] | |||||||||||||
Full Title: A pilot study of the treatment of facial nodular and nodulocystic basal cell carcinoma with double curettage and cautery followed by application of imiquimod to the base. | |||||||||||||
Medical condition: Basal Cell Carcinoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-004790-25 | Sponsor Protocol Number: FD-BZK | Start Date*: 2007-12-12 | |||||||||||
Sponsor Name:University of Leipzig | |||||||||||||
Full Title: Evaluation of the benefit of fluorescence diagnostics using Metvix® and the Dyaderm system for the preoperational estimation of the lateral tumour spread in basal cell carcinomas. | |||||||||||||
Medical condition: basal cell carcinoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-005769-12 | Sponsor Protocol Number: RD.03.SPR.29051 | Start Date*: 2006-06-12 | |||||||||||
Sponsor Name:Galderma R&D | |||||||||||||
Full Title: FLUORESCENT DETECTION WITH METHYL AMINOLEVULINATE OF BASAL CELL CARCINOMA: TO ASSESS THE ACCURACY OF THIS TECHNIQUE BY COMPARISON WITH RESECTION MARGIN LEFT BY MOH’S MICROGRAPHIC SURGERY AFTER DIF... | |||||||||||||
Medical condition: Basal Cell Carcinoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.